Abstract
This study aims to examine the impact of long-term treatment with the anti-TNF antibody infliximab on radiographic progression of hip arthritis in ankylosing spondylitis. Anteroposterior X-rays of the pelvis obtained at baseline from consecutive patients with ankylosing spondylitis and bilateral hip arthritis were compared with X-rays obtained after 6 ± 2.5 years (mean ± SD) of continuous infliximab treatment. Analysis was performed by the Bath Ankylosing Spondylitis Radiology Hip Index (BASRI-h) scoring system (min 0, max 4). Hip joint space width was also assessed by the average of measurements at three distinct sites between the acetabulum and femoral head. In 23 patients with active disease (21 men, mean age and disease duration of 45 and 16 years, respectively), the BASRI-h score at baseline was 1 in 7, 2 in 16, 3 in 16, and 4 in 7 hips (including two arthroplasties). Individual BASRI-h scores at baseline (2.50 ± 0.86, mean ± SD) remained unchanged in all patients at end of follow-up. At baseline, the average width of the whole joint space (3.56 ± 0.70 mm, n = 44) was not associated with disease activity measurements but negatively correlated with BAS functional index (Spearman r = −0.5, P = 0.007). After 2–10 years of infliximab treatment, the average width of the whole joint space in these patients (3.59 ± 0.79 mm) was not reduced. These results suggest that radiographic progression of hip arthritis in ankylosing spondylitis may be arrested during infliximab treatment.
Similar content being viewed by others
References
Vander Cruyssen B, Muñoz-Gomariz E, Font P, Mulero J, de Vlam K, Boonen A et al (2010) Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology 49:73–81
Boonen A, Cruyssen BV, de Vlam K, Steinfeld S, Ribbens C, Lenaerts J et al (2009) Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. J Rheumatol 36:1249–1255
Appel H, Kuhne M, Spiekermann S, Köhler D, Zacher J, Stein H et al (2006) Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone–cartilage interface and subchondral bone marrow. Arthritis Rheum 54:1805–1813
Baraliakos X, Listing J, Brandt J, Haibel H, Rudwaleit M, Sieper J et al (2007) Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-a antibody infliximab. Rheumatology 4:1450–1453
Baraliakos X, Haibel H, Listing J, Sieper J, Braun J (2011) Radiographic progression in ankylosing spondylitis—results after up to 8 years of infliximab treatment [abstract]. Arthritis Rheum 63(Suppl 10):208
Braun J, Kalden JR (2009) Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 27(Suppl 55):164–167
Goie HS, Steven MM, Van der Linden SM, Cats A (1985) Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 24:242–249
Maksymowych WP (2005) Novel therapies for ankylosing spondylitis. Curr Rheumatol Rep 7:182–187
MacKay K, Brophy S, Mack C, Doran M, Calin A (2000) The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol 27:2866–2872
Conrozier T, Lequesne MG, Tron AM, Mathieu P, Berdah L, Vignon E (1997) The effects of position on the radiographic joint space in osteoarthritis of the hip. Osteoarthr Cartil 5:17–22
Carlisle JC, Zebala LP, Shia DS, Hunt D, Morgan PM, Prather H et al (2011) Reliability of various observers in determining common radiographic parameters of adult hip structural anatomy. Iowa Orthop J 31:52–58
Maksymowych WP, Elewaut D, Schett G (2012) Motion for debate: the development of ankylosis in ankylosing spondylitis is largely dependent on inflammation. Arthritis Rheum 64:1713–1719
Sfikakis PP (2010) The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr Dir Autoimmun 11:180–210
Lian F, Yang X, Liang L, Xu H, Zhan Z, Qiu Q et al (2012) Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population. Rheumatol Int 32:1663–1667
Ostergaard M, Lambert RG (2012) Imaging in ankylosing spondylitis. Ther Adv Musculoskelet Dis 4:301–311
Baraliakos X, Braun J (2010) Hip involvement in ankylosing spondylitis: what is the verdict? Rheumatology 49:3–4
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Konsta, M., Sfikakis, P.P., Bournia, V.K. et al. Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis. Clin Rheumatol 32, 1229–1232 (2013). https://doi.org/10.1007/s10067-013-2263-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2263-x